PinUp: A Flood of Drug Adverse Event Reports, A Shower of Oxycodone Pills in...
Welcome to the March 21, 2017, issue of Pharma Industry News Update (aka PinUp). Of showers and floods. We all know that there is an opioid addiction epidemic and Sen. Sanders places at least some of the blame on the pharmaceutical industry that has showered rural America with drugs. This epidemic is causing a flood of adverse events; i.e., deaths! But adverse events due to other, more mainline prescription drugs are also at an all-time high.
PinUp: How to Succeed as a Chief Digital Officer in Pharma, Use of Digital...
Welcome to the March 14, 2017, issue of Pharma Industry News Update (aka PinUp). What does it take to be a successful digital leader - e.g., Chief Digital Officer (CDO) - in a big pharmaceutical company? Consultants at McKinsey & Company try to answer this question by interviewing executives at ten companies. Are they talking to the right people?
PinUp: Pharma’s Social Media Ennui & CME, Breakthrough Therapy Hype, Merck Seeks Digital Diabetes...
Welcome to the March 10, 2017, issue of Pharma Industry News Update (aka PinUp). QuintileIMS has a polite way of saying that pharma marketers are not paying enough attention to social media. But before pharma can effectively use social media, it has to first learn to be a trusted healthcare partner for patients and physicians. But that effort is often thwarted by drug ads that overhype the effectiveness of its products and alienating many physicians. It's as if one hand does not know what the other is doing.
PinUp: DTC Ad Spending Takes Off, Drug Approval Stats, Takeda Tests Apple Watch App...
Welcome to the March 7, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: WebMD & pharma’s Digital ad spend, FDA defends DTC studies, right-to-try survey results...
Welcome to the March 2, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: Top 10 drugs going off-patent, Soon, no more ED ads! 2016 was record...
Welcome to the February 28, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: Right to Try False Hopes, Bullshit Course, Debunking Fake News About Off-Label DTC...
Welcome to the February 21, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: Pharma CEOs’ Words of Wisdom Regarding Drug Prices, Jobs, and Taxes, more…
Welcome to the February 17, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: @Novartis Loves Disruptive Digital Technology & is Leading the Way, more…
Welcome to the February 14, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.
PinUp: Rewards vs Risks of Reciprocal Drug Approval, Kybella Sales Take it on the...
Welcome to the February 10, 2017, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.